Inside Valeant's Unknowns and Company Statement

Already a lightning rod for criticism over skyrocketing drug prices, Valeant Pharmaceuticals International Inc. plunged for a second day after a Wall Street short-seller published a report Wednesday scrutinizing its relationships with pharmacies, leading to a downgrade Thursday by a formerly bullish analyst at BMO Capital Markets. Citron Research Founder Andrew Left and Bloomberg's Drew Armstrong speak on "Bloomberg Markets." (Source: Bloomberg)

Full Show: What'd You Miss? (08/17)
32:17 - Guests include: Eurasia Group's Federico Santi, BMO Capital's Brian Belski, Geopolitical Futures founder George Friedman and Goldman Sachs & Co.'s Gary Chropuvka. (Source: Bloomberg)
  • Full Show: Bloomberg Daybreak: Americas (08/17)
  • Full Show: Surveillance (08/17)
  • Full Show: Bloomberg Technology (08/16)